The assertions made by the gentlemen from Evo Fund does ring very true if a study is made of Pryme executive remuneration over the past 6 years. The board in its request to shareholders to reject outright the marauders asserts that steps have been taken over the years to conserve cash and cut all discretionary expenditure.
Based on the annual reports in 2010 Justin Pettett's annual cash salary was $165,000. In 2014 is was $361,000. A 221% increase in the face of severely declining oil prices.
Justin Pettett's and Ryan Messer's total remuneration packages have consistently increased year on year from 2009 to 2014 as shareholder value has just as consistently eroded. Total executive remuneration as indicated in the reports has been around $900,000 per annum (it was $896,000 in 2009 and $909,000 in 2014). These numbers are only slightly below gross revenues of $1.270m in 2014 and $1.265m in 2013. The result is we as shareholders (I have held for the past 4 years) have watched as shareholder value has been steadily eroded with a significant amount of the constant diluting share issues simply going to the board and executive to keep them in the manner to which they have long been accustomed.
If the people from Evo can come in and curtail the remuneration haemorrhage maybe there is a significant benefit to be gained from the recently acquired assets?
- Forums
- ASX - By Stock
- Ann: Section 249D Notice
The assertions made by the gentlemen from Evo Fund does ring...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYM (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online